Intracellular uptake of thymidine and antiherpetic drugs for thymidine kinase-deficient mutants of herpes simplex virus type 1
- 20 February 2006
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 70 (3) , 93-104
- https://doi.org/10.1016/j.antiviral.2006.01.010
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Failure of Thymidine Kinase-Negative Herpes Simplex Virus To Reactivate from Latency following Efficient EstablishmentJournal of Virology, 2004
- Translational Compensation of a Frameshift Mutation Affecting Herpes Simplex Virus Thymidine Kinase Is Sufficient To Permit Reactivation from LatencyJournal of Virology, 2003
- Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trialsArchiv für die gesamte Virusforschung, 2003
- Selection of HSV-1 TK gene-transfected murine mammary carcinoma cells resistant to (E)-5-(2-bromovinyl)-2′-deoxyuridine (BVDU) and ganciclovir (GCV)Gene Therapy, 2000
- The structures of thymidine kinase fromHerpes simplexvirus type 1 in complex with substrates and a substrate analogueProtein Science, 1997
- The Herpes Simplex Virus Type 1 DNA Polymerase Gene: Site of Phosphonoacetic Acid Resistance Mutation in Strain Angelotti is Highly ConservedJournal of General Virology, 1987
- Nucleoside pools of acyclovir-treated herpes simplex type 1 infected cellsAntiviral Research, 1985
- Deoxyribonucleoside Triphosphate Pools in Herpes Simplex Type 1 Infected CellsJournal of General Virology, 1976
- Deoxypyrimidine Kinases of Herpes Simplex Viruses Types 1 and 2: comparison of Serological and Structural PropertiesJournal of General Virology, 1975
- Distinctive properties of thymidine kinase isozymes induced by human and avian herpesvirusesInternational Journal of Cancer, 1974